Literature DB >> 19724754

The use of placebo-controlled clinical trials for the approval of psychiatric drugs: part I-statistics and the case for the "greater good".

David Feifel1.   

Abstract

Entities:  

Year:  2009        PMID： 19724754      PMCID： PMC2719456     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN： 1550-5952


× No keyword cloud information.
  5 in total

1.  Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary?

Authors:  C Weijer
Journal:  Schizophr Res       Date:  1999-02-15       Impact factor: 4.939

2.  The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective.

Authors:  T P Laughren
Journal:  Eur Psychiatry       Date:  2001-11       Impact factor: 5.361

3.  Update on unethical use of placebos in randomised trials.

Authors:  Karin B Michels; Kenneth J Rothman
Journal:  Bioethics       Date:  2003-04       Impact factor: 1.898

4.  The lesser of 2 evils: the ethics of placebo-controlled trials.

Authors:  David L Streiner
Journal:  Can J Psychiatry       Date:  2008-07       Impact factor: 4.356

5.  The continuing unethical use of placebo controls.

Authors:  K J Rothman; K B Michels
Journal:  N Engl J Med       Date:  1994-08-11       Impact factor: 91.245
  5 in total
  4 in total

Review 1.  Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo-controlled trials.

Authors:  Joseph K Carpenter; Leigh A Andrews; Sara M Witcraft; Mark B Powers; Jasper A J Smits; Stefan G Hofmann
Journal:  Depress Anxiety       Date:  2018-02-16       Impact factor: 6.505

2.  Local IRBs vs. federal agencies: shifting dynamics, systems, and relationships.

Authors:  Robert L Klitzman
Journal:  J Empir Res Hum Res Ethics       Date:  2012-07       Impact factor: 1.742

3.  The Use of Placebo-Controlled Clinical Trials for the Approval of Psychiatric Drugs: Part II-Ethical Considerations Related to the Individual Participant.

Authors:  David Feifel
Journal:  Psychiatry (Edgmont)       Date:  2009-12

Review 4.  Zuclopenthixol versus placebo for schizophrenia.

Authors:  Michael Lacey; Mahesh B Jayaram
Journal:  Cochrane Database Syst Rev       Date:  2015-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.